We investigated the attachment and spreading of v-Crktransformed cells, v-Crk3Y1, on ®bronectin. Transformation by v-Crk virtually suppressed the spreading, but not the attachment, of cells on ®bronectin. This suppression of cell spreading was not correlated with the suppression of integrin a5 and b1 expression. However, the spreading of v-Crk3Y1 on ®bronectin was dramatically restored by either expression of dominantnegative Ras or treatment with manumycin A, a Ras farnesyltransferase inhibitor. Moreover, both expression of dominant-negative MEK1 and treatment of cells with U0126, a MEK1 inhibitor, restored the cell spreading of v-Crk3Y1. In contrast, neither treatment with LY294002, a PI3K inhibitor, nor expression of dominant-negative C3G showed no eect on cell spreading on ®bronectin. Taken together, our results suggest that, among multiple signaling pathways activated by v-Crk, the Ras-MEK1-MAP kinase cascade plays a pivotal role in the suppression of cell spreading on ®bronectin, but C3G and the PI3 kinase do not. Oncogene (2001) 20, 5908 ± 5912.
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Keywords: v-Crk; Ras; MAP kinase; cell spreading; integrin One striking aspect of the phenotype of transformed cells is reduced adhesion to solid substrates. Many transformed cells fail to spread as extensively as do their normal counterparts and grow independent of substrate contact (Plantefaber and Hynes, 1989) . Since this phenomenon appears to re¯ect the tumorigenic potential of cells, extensive studies have been made. In earlier studies, abnormalities in ®bronectin (FN), a major component of the extracellular matrix, and its receptor, integrin a5b1, have been identi®ed. While many of the transformed cells have reduced amounts of FN Adams et al., 1977) , cells transformed with src or ras have dramatically reduced levels of integrin a5b1 and hence a diminished ability to adhere to FN (Plantefaber and Hynes, 1989) .
Integrins are heteromeric transmembrane cell adhesion receptors comprising a-and b-subunits (Hynes, 1992) . From 16 dierent a-and eight b-subunits, at least 20 dierent heterodimers are produced, giving the variety of integrin function. The discovery of integrin as a signaling molecule (Hynes, 1992) lead to the study of cell spreading as a bi-directional signaling event,`outside to in' and`inside to out'. While ligand binding and integrin aggregation are sucient to recruit signaling molecules to the integrin clustered sites (Miyamoto et al., 1995) , various intracellular signaling can control focal adhesion formation (Clark and Brugge, 1995) . For example, v-Src induces tyrosine phosphorylation of cellular proteins including FAK and p130 cas at focal adhesion plaques with the disassembly of the plaques (Nigg et al., 1986; Guan and Shalloway, 1992) . While FAKde®cient cells have reduced cell mobility and an increased number of focal adhesions (Ilic et al., 1995) , p130 cas -de®cient cells exhibits a signi®cant delay in cell spreading on FN, suggesting the involvement of these proteins in cell spreading. But the mechanism by which they are involved in cell spreading is still largely obscure.
To obtain more clues, we investigated the adhesive behavior of v-Crk-transformed cells, because the regulation of cell spreading by adapter-type oncogenes remains unclear. v-Crk, the ®rst member of adaptertype oncogenes, consists of a viral Gag sequence fused to the SH2 and the SH3 domains (Mayer et al., 1988) . While its SH2 domain binds tyrosine phosphorylated proteins including p130 cas and Paxillin (Birge et al., 1996) , the SH3 domain binds proline-rich sequences of proteins including SOS and C3G (Tanaka et al., 1997) . The binding of Crk with SOS appears to activate the Ras-MAPK pathway (Greulich and Hanafusa, 1996) , whereas its binding to C3G activates JNK in a Rasindependent manner (Tanaka et al., 1997) . In addition, v-Crk induces tyrosine phosphorylation of cellular proteins including p130 cas , although it has no catalytic kinase domain. Expression of protein tyrosine phosphatase 1B inhibited cell transformation by v-Crk (Liu et al., 1998) , suggesting a critical role of tyrosine phosphorylation. Although the basic nature of the signaling pathways activated by v-Crk has been well studied, whether and how v-Crk suppresses cell spreading remains unclear. Here we show for the ®rst time that v-Crk suppresses cell spreading onto FN via the Ras-MAPK pathway.
Rat cell lines, 3Y1, 3Y1 transformed with v-Crk (vCrk3Y1) or with v-Src (SR3Y1) were used throughout the study. In the case of v-Crk3Y1, 3Y1 was transfected with the v-crk gene ligated with the pMEXneo vector, and drug-resistant cells pooled were used for this study. Since cells transformed with the src oncogene lead to reductions in the level of integrin a5 and b1 (Plantefaber and Hynes, 1989), we ®rst examined the levels of integrin a5 and b1 in these cells. In SR3Y1, the relative levels of a5 and b1 integrins, especially b1, were substantially decreased compared with those of 3Y1 as previously reported. It was somewhat unexpected, however, that the relative levels of integrin a5 and b1, especially b1, were rather increased in v-Crk3Y1 ( Figure 1a ). We examined the formation of F-actin and adhesion structure in vCrk3Y1 by staining with rhodamine-conjugated phalloidin and anti-vinculin antibody. Compared with normal 3Y1, clear formation of F-actin bundles and accumulation of vinculin at the site of focal contact was lost in v-Crk3Y1 (Figure 1d ), although integrin a5 and b1 were over-expressed.
When 3Y1 and v-Crk3Y1 were trypsinized and plated onto FN-coated dishes, both cells attached well on dishes to the same extent. However, we found striking dierences in the appearance of cell spreading on FN-coated dishes. As shown in Figure  1 , plated cells were incubated for the indicated times and the extent of cell spreading was assayed. Within 10 min after plating, 30% of 3Y1 had already started to spread, and approximately 50% of them attained a¯at morphology at 20 min. At 60 min after plating, nearly 90% of 3Y1 cells appeared well extended and had achieved a¯attened morphology. In contrast, vCrk3Y1, although expressing high levels of integrin a5 and b1, showed strongly reduced levels of spreading. At 10 min after plating, less than 10% of v-Crk3Y1 started spreading. At 20 min, approximately 20% showed spreading, and only 60% of the 5 cells of either 3Y1 or v-Crk3Y1 were seeded to the plates for a ®nal volume of 2 ml. Cells were allowed to spread for the indicated times at 378C and ®xed. Random ®elds were photographed using a phase-contrast microscope. Spread cells were not round, not phasebright, and had extended processes, whereas unspread cells were round and phase-bright. Bar, 12.5 mm. Although integrin a5 and b1 was over-expressed, cell spreading and formation of focal contact were both suppressed in v-Crk3Y1, suggesting the involvement of the intracellular signaling pathways in the suppression. Among the multiple signaling pathways activated by vCrk, we ®rst examined the role of Ras in cell spreading. We established v-Crk3Y1 transfected with conditionally inducible S17N ras. S17N Ras, a mutant Ras with Asn substitution for Ser at position 17 of Ras H , yields a dominant inhibitory eect on endogenous Ras (Feig and Cooper, 1988) . Under the control of MMTV promoter/enhancer, S17N ras was induced by treatment with dexamethasone ( Figure 2a ). The results with two representative clones were showed. We con®rmed that the Ras-bound GTP/GDP ratio was dramatically decreased by dexamethasone treatment (Liu et al., 2000) . MAP kinase activities were strongly inhibited by the expression of S17N Ras (Figure 2b ). In contrast, dexamethasone treatment of S17N rastransfected v-Crk3Y1 did not inhibit tyrosine phosphorylation of cellular proteins (Figure 2d ). Tyrosine phosphorylation of paxillin and p130 cas was not suppressed by S17N Ras expression (Figure 2e ). We found, however, that expression of S17N Ras in vCrk3Y1 dramatically rescued the cell spreading on FN (Figure 3) .
We next studied the role of MEK1, a major downstream eector for Ras, in cell spreading. In earlier studies, Ras was found to mediate its eects on cellular proliferation by the activation of a linear cascade of kinases; Raf, MEK and MAP kinases (ERK1/2) (Egan and Weinberg, 1993). However, a large body of evidence suggests that Ras signaling involves a complex array of signaling pathways such as PI3 kinase, RalGDS, SEK-JNK, p120GAP, RIN1, NF1 GAP and AF6 (Campbell et al., 1998) . As a step to identify the critical downstream eector, we examined the eect of expressing dominant-negative MEK1 (MEK1AA; Kurata et al., 2000) in v-Crk3Y1. A Myc-epitope tagged MEK1AA gene was introduced into v-Crk3Y1 by electroporation (Liu et al., 2000) . As shown in Figure 3c , cell spreading recovered in MEK1AA-expressing v-Crk3Y1 but not in surrounding ME-K1AA-negative cells. We next examined the role of the C3G pathway in the suppression of cell spreading by use of a dominant-negative form of C3G. Dominantnegative C3G was transiently introduced into vCrk3Y1 by electroporation and its expression was monitored by immunoblotting (data not shown, Liu et al., 2000) . We found that cell spreading was not rescued by the expression of dominant-negative C3G (Figure 3d ).
To con®rm these observations, we next examined the eects of various chemical inhibitors on the spreading of v-Crk3Y1 (Figure 4) . When v-Crk3Y1 was pretreated with manumycin A, a potent inhibitor of Ras farnesyltransferase (Liu et al., 2000) , cell spreading recovered well (Figure 4 ). Under these conditions, both the expression of v-Crk and the tyrosine phosphorylation of cellular proteins in v-Crk3Y1 were not perturbed by the drug treatment (data not shown). Similarly, v-Crk3Y1 treated with U0126, a potent inhibitor of MEK1, showed recovery of cell spreading to a level similar to that of 3Y1, while v-Crk expression and cellular protein phosphorylation were not inhibited (data not shown). In contrast to these inhibitors, LY294002, a potent inhibitor of PI3 kinase, did not show rescue cell spreading in v-Crk3Y1 (Figure 4) . In contrast to v-Crk3Y1, treatment of 3Y1 with U0126 resulted in weak suppression of cell spreading (Figure 4b) . Similar results were reported by Fincham (2000) that U0126 treatment of Rat embryo ®broblast REF52 resulted in the suppression of cell spreading. Both normal and v-Crk-transformed cells require MEK-MAP kinase signaling for the control of cell spreading, but the MEK inhibitor appears to produce opposite eects in the two types of cells. Although further experiments are required, constitutive activation of the MEK-MAP kinase pathway and/or its interaction with other signaling pathway in v-Crk3Y1 might account for the dierent eects of MEK inhibitors on cell spreading of normal versus v-Crktransformed cells.
Recently Tanaka et al. (1997) reported that overexpression of a dominant-negative form of C3G abolished both the JNK activity and the colonyforming potential of v-Crk NIH3T3. More recently, Akagi et al. (2000) reported that activation of the PI3K-AKT pathway was required for the anchorageindependent growth of v-Crk-transformed chicken embryonic ®broblasts. In contrast, we found that neither expression of dominant-negative C3G nor treatment of v-Crk3Y1 with LY294002 restored the cell spreading. Our results suggest that both C3G and PI3K are dispensable for the suppression of cell spreading, whereas Ras-MEK1 plays a pivotal role in it. Our results also suggest that tyrosine phosphorylation of cellular proteins including p130 cas is not sucient for the inhibition of cell spreading.
In summary, we showed for the ®rst time that v-Crk suppresses cell spreading in a Ras-MEK1-dependent manner. Further studies including the identi®cation of downstream factor(s) that regulate cell spreading are required for the complete comprehension of cell transformation by v-Crk.
